Physician profile
Prince Shah
NPI 1174632251
$14,463.28
in general payments reported to CMS, 2019-2025
17 companies · $5,069 in 2025
The $5,069 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $15.80 · 2022: $7,042 · 2023: $790 · 2024: $1,264 · 2025: $5,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,780 · Consulting Fee: $1,545 · Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,780.40 |
| Consulting Fee | $1,545.00 |
| Food and Beverage | $796.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,452.71 | 2022-2024 | Pillcam |
| Intuitive Surgical, INC. | $4,782.25 | 2025 | |
| Abbvie INC. | $483.07 | 2019-2025 | Linzess, Mavyret, Creon |
| Pfizer INC. | $219.33 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $109.53 | 2019-2025 | Entyvio |
| Boston Scientific Corporation | $92.32 | 2022-2023 | Cre Pro |
| Lilly USA, LLC | $62.41 | 2024-2025 | Omvoh |
| Braintree Laboratories, INC. | $53.32 | 2019 | |
| Phathom Pharmaceuticals, INC. | $36.09 | 2024-2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $34.79 | 2019 | |
| Merck Sharp & Dohme LLC | $34.32 | 2019-2023 | Dificid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.62 | 2025 | Xifaxan |
| Vivus LLC | $20.13 | 2022 | |
| Azurity Pharmaceuticals, INC. | $18.22 | 2025 | Sutab |
| Ferring Pharmaceuticals INC. | $13.99 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $13.59 | 2025 | Conmed Biopsy, Conmed Hemostasis, Conmed Dilation |
| Ardelyx, INC. | $13.59 | 2023 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prince Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.